Abstract
Liver cirrhosis is the end stage of chronic liver disease, and the only radical treatment for decompensated liver cirrhosis is still liver transplantation. Development of effective regenerative therapy for liver cirrhosis is an urgent task. Before human clinical trials can be considered, the safety and efficacy of any planned protocol must be confirmed in medium-to-large animals. Therefore, we have developed a novel canine liver fibrosis model for proof of concept (POC) studies.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsSpringer Nature is developing a new tool to find and evaluate Protocols. Learn more
References
Takami T, Terai S, Sakaida I (2012) Stem cell therapy in chronic liver disease. Curr Opin Gastroenterol 28(3):203–208. https://doi.org/10.1097/MOG.0b013e3283521d6a
Terai S, Sakaida I, Yamamoto N, Omori K, Watanabe T, Ohata S, Katada T, Miyamoto K, Shinoda K, Nishina H, Okita K (2003) An in vivo model for monitoring trans-differentiation of bone marrow cells into functional hepatocytes. J Biochem 134(4):551–558
Sakaida I, Terai S, Yamamoto N, Aoyama K, Ishikawa T, Nishina H, Okita K (2004) Transplantation of bone marrow cells reduces CCl4-induced liver fibrosis in mice. Hepatology 40(6):1304–1311. https://doi.org/10.1002/hep.20452
Terai S, Ishikawa T, Omori K, Aoyama K, Marumoto Y, Urata Y, Yokoyama Y, Uchida K, Yamasaki T, Fujii Y, Okita K, Sakaida I (2006) Improved liver function in patients with liver cirrhosis after autologous bone marrow cell infusion therapy. Stem Cells 24(10):2292–2298. https://doi.org/10.1634/stemcells.2005-0542. pii: 2005-0542
Kim JK, Park YN, Kim JS, Park MS, Paik YH, Seok JY, Chung YE, Kim HO, Kim KS, Ahn SH, Kim do Y, Kim MJ, Lee KS, Chon CY, Kim SJ, Terai S, Sakaida I, Han KH (2010) Autologous bone marrow infusion activates the progenitor cell compartment in patients with advanced liver cirrhosis. Cell Transplant 19(10):1237–1246. https://doi.org/10.3727/096368910X506863
Kim JK, Kim SJ, Kim Y, Chung YE, Park YN, Kim HO, Kim JS, Park MS, Sakaida I, Kim DY, Lee JI, Ahn SH, Lee KS, Han KH (2017) Long-term follow-up of patients after autologous bone marrow cell infusion for decompensated liver cirrhosis. Cell Transplant 26(6):1059–1066. https://doi.org/10.3727/096368917X694778
Tanimoto H, Terai S, Taro T, Murata Y, Fujisawa K, Yamamoto N, Sakaida I (2013) Improvement of liver fibrosis by infusion of cultured cells derived from human bone marrow. Cell Tissue Res 354(3):717–728. https://doi.org/10.1007/s00441-013-1727-2
Quintanilha LF, Takami T, Hirose Y, Fujisawa K, Murata Y, Yamamoto N, Goldenberg RC, Terai S, Sakaida I (2014) Canine mesenchymal stem cells show antioxidant properties against thioacetamide-induced liver injury in vitro and in vivo. Hepatol Res 44(10):E206–E217. https://doi.org/10.1111/hepr.12204
Matsuda T, Takami T, Sasaki R, Nishimura T, Aibe Y, Paredes BD, Quintanilha LF, Matsumoto T, Ishikawa T, Yamamoto N, Tani K, Terai S, Taura Y, Sakaida I (2017) A canine liver fibrosis model to develop a therapy for liver cirrhosis using cultured bone marrow-derived cells. Hepatol Commun 1(7):691–703. https://doi.org/10.1002/hep4.1071
Acknowledgments
The development of this model was supported by the Japanese highway program for the realization of regenerative medicine of the Japan Science and Technology Agency (JST) and the Japan Agency for Medical Research and Development (AMED) and by JSPS KAKENHI grant numbers JP17H04162 to I.S. and JP17K09428 to T.T. We also thank the members involved in this model, Luiz Fernando Quintanilha, Takashi Matsuda, Bruno Diaz Paredes, Yuki Aibe, Ryo Sasaki, Tatsuro Nishimura, Toshihiko Matsumoto, Tsuyoshi Ishikawa, Naoki Yamamoto, Yasuhisa Oishi, Ikuyo Yoshida, Koushiro Ozono, Takafumi Kanematsu, Katsuhiro Kesamaru, Hironori Morisaki, Miku Yamashita, Yutaro Kitaura, Ko Nakasumi, Kazuaki Igari, Shotaro Eto, Kyosuke Hidari, Masahiro Imagawa, Tsunehiro Isozaki, Kentaro Itoh, Haruhi Sakai, Mai Sakai, Hiroya Inoue, Fumiya Yamane, Masato Hiyama, and Saori Shinzato.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Science+Business Media, LLC, part of Springer Nature
About this protocol
Cite this protocol
Takami, T., Tani, K., Taura, Y., Sakaida, I. (2019). Canine Liver Fibrosis Model to Assess the Functions of Infused Autologous Bone Marrow-Derived Cells. In: Tanimizu, N. (eds) Hepatic Stem Cells . Methods in Molecular Biology, vol 1905. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-8961-4_18
Download citation
DOI: https://doi.org/10.1007/978-1-4939-8961-4_18
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-8960-7
Online ISBN: 978-1-4939-8961-4
eBook Packages: Springer Protocols